PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2007
|
| _version_ | 1797097380991991808 |
|---|---|
| author | Keshav, S Petryka, R Vanask, T Niv, Y Marlicz, K Haagen-Nielsen, O Machado, M Dahlerup, J Schreiber, S Bekker, P Sankar, S Schall, T |
| author_facet | Keshav, S Petryka, R Vanask, T Niv, Y Marlicz, K Haagen-Nielsen, O Machado, M Dahlerup, J Schreiber, S Bekker, P Sankar, S Schall, T |
| author_sort | Keshav, S |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T04:54:40Z |
| format | Conference item |
| id | oxford-uuid:d62f7a1f-2809-4023-9130-69fef667f7cd |
| institution | University of Oxford |
| last_indexed | 2024-03-07T04:54:40Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:d62f7a1f-2809-4023-9130-69fef667f7cd2022-03-27T08:31:31ZPROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's diseaseConference itemhttp://purl.org/coar/resource_type/c_5794uuid:d62f7a1f-2809-4023-9130-69fef667f7cdSymplectic Elements at Oxford2007Keshav, SPetryka, RVanask, TNiv, YMarlicz, KHaagen-Nielsen, OMachado, MDahlerup, JSchreiber, SBekker, PSankar, SSchall, T |
| spellingShingle | Keshav, S Petryka, R Vanask, T Niv, Y Marlicz, K Haagen-Nielsen, O Machado, M Dahlerup, J Schreiber, S Bekker, P Sankar, S Schall, T PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease |
| title | PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease |
| title_full | PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease |
| title_fullStr | PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease |
| title_full_unstemmed | PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease |
| title_short | PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease |
| title_sort | protect 1 a prospective randomized trial of ccx282 b traficet en a novel oral therapy targeting chemokine receptor 9 in crohn s disease |
| work_keys_str_mv | AT keshavs protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT petrykar protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT vanaskt protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT nivy protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT marliczk protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT haagennielseno protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT machadom protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT dahlerupj protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT schreibers protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT bekkerp protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT sankars protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease AT schallt protect1aprospectiverandomizedtrialofccx282btraficetenanoveloraltherapytargetingchemokinereceptor9incrohnsdisease |